rilonacept 220 MG Injection

RxCUI
763453
RxNorm name
rilonacept 220 MG Injection
Display name
rilonacept 220 MG Injection
Full name
rilonacept 220 MG Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:15

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125249Arcalystrilonacept351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ArcalystRILONACEPTKiniksa Pharmaceuticals (UK), Ltd.ad965f38-dd22-4607-a673-2fb92f3b527a2025-12-16Warnings, Adverse reactionsExact identifier
rxcui: 763453

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
ad965f38-dd22-4607-a673-2fb92f3b527arilonacept 220 MG InjectionPSN16These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST ® (rilonacept) for injection, for subcutaneous use Initial U.S. Approval: 200820251216
ad965f38-dd22-4607-a673-2fb92f3b527arilonacept 220 MG InjectionSCD16These highlights do not include all the information needed to use ARCALYST safely and effectively. See full prescribing information for ARCALYST. ARCALYST ® (rilonacept) for injection, for subcutaneous use Initial U.S. Approval: 200820251216